Patient S.E., male, age 77 years old, had a history of previous intravitreal injections with anti-VEGF therapy (Aflibercept) in the right eye (OD) for the treatment of the macular edema associated with wet-AMD, the last one being administered 3 days before presentation. The gene discussed is VEGFA; the disease is wet macular degeneration.